MedPath
NMPA Approval

Adalimumab Solution for Injection

国药准字S20220001

January 18, 2022

Drug Information

阿达木单抗注射液

泰博维

注射剂

40mg(0.8ml)/支

生物制品

January 18, 2022

Company Information

Applicant Company

南京市江宁区福英路1099号(江宁高新园)

Manufacturing Company

南京市江宁区福英路1099号(江宁高新园)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.